CDAK

Codiak BioSciences, Inc. Common Stock
CDAK

Delisted

CDAK was delisted on the 4th of April, 2023.

Back to rankings
 

About: Codiak BioSciences Inc is a development-stage biopharmaceutical company focused on the development of exosome-based therapeutics for the treatment of a wide spectrum of diseases with high unmet medical need. The company have utilized engEx Platform to generate a pipeline of engineered exosomes, aimed at treating a broad range of diseases, including oncology, neuro-oncology, neurology, neuromuscular disease, infectious disease and rare disease.

Employees: 53

Healthcare Drug Manufacturers - General
Charts implemented using Lightweight Charts™